Highland Capital Management (Texas)’s Sage Therapeutics SAGE Stock Holding History

Highland Capital Management (Texas)’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,955	Closed	-$311K	–	359
2019 Q1	$311K	Sell	1,955 -5,045	-72%	-$731K	0.02%	272
2018 Q4	$671K	Buy	7,000 +3,000	+75%	+$343K	0.05%	183
2018 Q3	$565K	Hold	4,000	–	–	0.03%	208
2018 Q2	$626K	Sell	4,000 -2,000	-33%	-$314K	0.04%	195
2018 Q1	$966K	Sell	6,000 -8,000	-57%	-$1.36M	0.05%	185
2017 Q4	$2.31M	Sell	14,000 -6,000	-30%	-$582K	0.11%	135
2017 Q3	$1.25M	Sell	20,000 -4,300	-18%	-$338K	0.05%	178
2017 Q2	$1.94M	Sell	24,300 -25,350	-51%	-$1.83M	0.08%	147
2017 Q1	$3.53M	Buy	+49,650	New	+$2.91M	0.18%	119
2016 Q1	–	Sell	-152,985	Closed	-$8.92M	–	265
2015 Q4	$8.92M	Buy	+152,985	New	+$7.58M	0.29%	105

Other funds holding SAGE

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Highland Capital Management (Texas)'s SAGE Position: Q2 2019 in Review

Highland Capital Management (Texas) sold out of Sage Therapeutics (SAGE) in Q2 2019, closing a stake of 1,955 shares — an estimated $311K sold.

Highland Capital Management (Texas) first reported a position in SAGE in Q4 2015 and held it in 10 quarters. The position peaked at $8.92M in Q4 2015. 272 funds tracked by Wall St. Rank hold SAGE as of Q2 2019.

Highland Capital Management (Texas) reported no remaining Sage Therapeutics position as of Q2 2019 after selling out during the quarter.
Highland Capital Management (Texas) sold 1,955 Sage Therapeutics shares in Q2 2019, an estimated $311K.
Highland Capital Management (Texas) first reported a position in Sage Therapeutics in Q4 2015 and held it in 10 quarters.
Highland Capital Management (Texas)'s Sage Therapeutics position peaked at $8.92M in Q4 2015.
272 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.